ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 313,56
-0,57%
Dow Jones
42 718,90
-0,64%
DAX
19 909,14
-0,25%
Brent Oil
74,105
0,65%
Bitcoin
94 288,97
0,82%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Lantheus Holdings Inc (LNTH) Cours

Lantheus Holdings Inc

Lantheus Holdings Inc (LNTH)

NASDAQ
89,8857
-2,18
( -2,37% )
Mis à jour : 19:24:36
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
89,8857
Prix Achat
89,79
Prix Vente
89,90
Volume échangé
166 109
89,79 Fourchette du Jour 91,79
50,20 Plage de 52 semaines 126,8899
Cap du marché
6,249B
Clôture Veille
92,07
Ouverture
91,79
Dernière Transaction
1
@
89.8694
Dernière heure de transaction
19:24:42
Volume financier
US$ 15 033 790
VWAP
90,5056
Volume moyen (3 m)
1 035 612
Actions en circulation
69 526 841
Rendement du Dividende
-
Ratio Cours sur Bénéfices
19,15
Bénéfice par action (BPA)
4,7
Chiffre d'affairess
1,3B
Bénéfice net
326,66M

À propos de Lantheus Holdings Inc

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in ... Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States. Show more

Secteur
In Vitro,in Vivo Diagnostics
Industrie
In Vitro,in Vivo Diagnostics
Site Web
www.lantheus.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Lantheus Holdings Inc est coté dans le secteur In Vitro,in Vivo Diagnostics de la NASDAQ avec le ticker LNTH. Le dernier cours de clôture d'Lantheus était de US$92,07. Au cours de la dernière année, les actions de Lantheus ont été négociées dans une fourchette de prix de US$ 50,20 à US$ 126,8899.

Lantheus compte actuellement 69 526 841 actions en circulation. La capitalisation boursière d'Lantheus est de US$6,40 milliard. Lantheus a un ratio cours/bénéfice (ratio PE) de 19.15.

LNTH Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

23 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

19 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

20 Novembre 2024
Edgar (US Regulatory)

Lantheus Announces Share Repurchase Program

BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling...

20 Novembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

19 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Novembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

15 Novembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

14 Novembre 2024
Edgar (US Regulatory)

Lantheus to Present at the Jefferies London Healthcare Conference

BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...

13 Novembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

12 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.1143-0.1279093.2988.5239376691.93412484CS
40.24570.27409638554289.6496.06586.7285789390.92353943CS
12-17.3543-16.1826743752107.24118.2175103561293.46144457CS
269.535711.867703795980.35126.8899751022408100.9003756CS
5227.985745.211147011361.9126.889950.2100354983.38878025CS
15660.0557201.32651692929.83126.889923.51108228172.13583823CS
26069.5157341.26509572920.37126.88998.6785753058.78442248CS

LNTH - Frequently Asked Questions (FAQ)

What is the current Lantheus share price?
The current share price of Lantheus is US$ 89,8857
How many Lantheus shares are in issue?
Lantheus has 69 526 841 shares in issue
What is the market cap of Lantheus?
The market capitalisation of Lantheus is USD 6,4B
What is the 1 year trading range for Lantheus share price?
Lantheus has traded in the range of US$ 50,20 to US$ 126,8899 during the past year
What is the PE ratio of Lantheus?
The price to earnings ratio of Lantheus is 19,15
What is the cash to sales ratio of Lantheus?
The cash to sales ratio of Lantheus is 4,83
What is the reporting currency for Lantheus?
Lantheus reports financial results in USD
What is the latest annual turnover for Lantheus?
The latest annual turnover of Lantheus is USD 1,3B
What is the latest annual profit for Lantheus?
The latest annual profit of Lantheus is USD 326,66M
What is the registered address of Lantheus?
The registered address for Lantheus is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Lantheus website address?
The website address for Lantheus is www.lantheus.com
Which industry sector does Lantheus operate in?
Lantheus operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NXUNXU Inc
US$ 1,6989
(597,99%)
501,66M
WATTEnergous Corporation
US$ 1,45
(252,63%)
171,38M
INTZIntrusion Inc
US$ 5,12
(137,04%)
120,09M
AERTAeries Technology Inc
US$ 2,07
(136,06%)
3,86M
SMXSMX Security Matters Public Company
US$ 0,7701
(117,79%)
255,2M
ABPAbpro Holdings Inc
US$ 2,12
(-52,78%)
1,59M
TRAWTraws Pharma Inc
US$ 8,07
(-39,87%)
958,15k
LITMSnow Lake Resources Ltd
US$ 1,16
(-27,50%)
47,54M
DOMHDominari Holdings Inc
US$ 0,8391
(-27,03%)
154,06k
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 67,89
(-23,26%)
13,31k
NXUNXU Inc
US$ 1,6989
(597,99%)
505,03M
VINCVincerx Inc
US$ 0,344
(77,32%)
313,84M
SMXSMX Security Matters Public Company
US$ 0,7701
(117,79%)
255,83M
XTIAXTI Aerospace Inc
US$ 0,03995
(1,14%)
206,47M
WATTEnergous Corporation
US$ 1,45
(252,63%)
172,12M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
LNTH
Lantheus
TSXV
BTR
BonTerra Resources
TG
A3LA6E
Agence France
AMEX
SPUC
Simplify Us Equity Plus ...
NYSE
ZTS
Zoetis
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés